1.Bikle, DD (2011) Vitamin D: an ancient hormone. Exp Dermatol 20, 7–13.
2.Wacker, M & Holick, MF (2013) Vitamin D– effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 5, 111–148.
3.Heath, KM & Elovic, EP (2006) Vitamin D deficiency: implications in the rehabilitation setting. Am J Phys Med Rehabil 85, 916–923.
4.Gendelman, O, Itzhaki, D, Makarov, S, et al. (2015) A randomized double-blind placebo-controlled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain. Lupus 24, 483–489.
5.Daly, RM, Gagnon, C, Lu, ZX, et al. (2012) Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol (Oxf) 77, 26–35.
6.Girgis, CM, Clifton-Bligh, RJ, Turner, N, et al. (2014) Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf) 80, 169–181.
7.Chowdhury, R, Kunutsor, S, Vitezova, A, et al. (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348, g1903.
8.Pfotenhauer, KM & Shubrook, JH (2017) Vitamin D deficiency, its role in health and disease, and current supplementation recommendations. J Am Osteopath Assoc 117, 301–305.
9.Herrmann, M, Sullivan, DR, Veillard, AS, et al. (2015) Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 38, 521–528.
10.Calton, EK, Keane, KN, Newsholme, P, et al. (2015) The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLOS ONE 10, e0141770.
11.Hassan-Smith, ZK, Jenkinson, C, Smith, DJ, et al. (2017) 25-Hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression. PLOS ONE 12, e0170665.
12.Simpson, RU, Thomas, GA & Arnold, AJ (1985) Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 260, 8882–8891.
13.Antinozzi, C, Corinaldesi, C, Giordano, C, et al. (2017) Potential role for the VDR agonist elocalcitol in metabolic control: evidences in human skeletal muscle cells. J Steroid Biochem Mol Biol 167, 169–181.
14.Pojednic, RM, Ceglia, L, Olsson, K, et al. (2015) Effects of 1, 25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin D receptor in human skeletal muscle cells. Calcif Tissue Int 96, 256–263.
15.Pfeifer, M, Begerow, B & Minne, HW (2002) Vitamin D and muscle function. Osteoporos Int 13, 187–194.
16.Campbell, PM & Allain, TJ (2006) Muscle strength and vitamin D in older people. Gerontology 52, 335–338.
17.Ceglia, L (2008) Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 29, 407–414.
18.Lappe, J, Cullen, D, Haynatzki, G, et al. (2008) Calcium and vitamin D supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res 23, 741–749.
19.Dahlquist, DT, Dieter, BP & Koehle, MS (2015) Plausible ergogenic effects of vitamin D on athletic performance and recovery. J Int Soc Sports Nutr 12, 33.
20.Bergman, P, Lindh, AU, Bjorkhem-Bergman, L, et al. (2013) Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. PLOS ONE 8, e65835.
21.Chiang, CM, Ismaeel, A, Griffis, RB, et al. (2017) Effects of vitamin D supplementation on muscle strength in athletes: a systematic review. J Strength Cond Res 31, 566–574.
22.Salminen, M, Saaristo, P, Salonoja, M, et al. (2015) Vitamin D status and physical function in older Finnish people: a one-year follow-up study. Arch Gerontol Geriatr 61, 419–424.
23.Olsson, K, Saini, A, Stromberg, A, et al. (2016) Evidence for vitamin D receptor expression and direct effects of 1α,25(OH)2D3 in human skeletal muscle precursor cells. Endocrinology 157, 98–111.
24.Ryan, ZC, Craig, TA, Folmes, CD, et al. (2016) 1α, 25-Dihydroxyvitamin D3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells. J Biol Chem 291, 1514–1528.
25.Owens, DJ, Sharples, AP, Polydorou, I, et al. (2015) A systems-based investigation into vitamin D and skeletal muscle repair, regeneration, and hypertrophy. Am J Physiol Endocrinol Metab 309, E1019–E1031.
26.Calton, EK, Pathak, K, Soares, MJ, et al. (2016) Vitamin D status and insulin sensitivity are novel predictors of resting metabolic rate: a cross-sectional analysis in Australian adults. Eur J Nutr 55, 2075–2080.
27.Chen, TC, Chimeh, F, Lu, ZR, et al. (2007) Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 460, 213–217.
28.Armas, LA, Hollis, BW & Heaney, RP (2004) Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89, 5387–5391.
29.Heaney, RP & Holick, MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26, 455–457.
30.Girgis, CM, Clifton-Bligh, RJ, Hamrick, MW, et al. (2013) The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 34, 33–83.
31.Norman, AW, Nemere, I, Zhou, LX, et al. (1992) 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 41, 231–240.
32.Chun, RF, Peercy, BE, Orwoll, ES, et al. (2014) Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144, 132–137.
33.Tsuprykov, O, Chen, X, Hocher, CF, et al. (2018) Why should we measure free 25(OH) vitamin D? J Steroid Biochem Mol Biol 180, 87–104.
34.Powe, CE, Evans, MK, Wenger, J, et al. (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369, 1991–2000.
35.Bikle, DD, Gee, E, Halloran, B, et al. (1986) Assessment of the free fraction of 25-hydroxyvitamin-D in serum and its regulation by albumin and the vitamin-D-binding protein. J Clin Endocr Metab 63, 954–959.
36.Powe, CE, Ricciardi, C, Berg, AH, et al. (2011) Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26, 1609–1616.
37.Shieh, A, Chun, RF, Ma, C, et al. (2016) Effects of high-dose vitamin D2 versus D3 on total and free 25-hydroxyvitamin D and markers of calcium balance. J Clin Endocrinol Metab 101, 3070–3078.
38.Allison, RJ, Farooq, A, Cherif, A, et al. (2018) Why don’t serum vitamin D concentrations associate with BMD by DXA? A case of being ‘bound’ to the wrong assay? Implications for vitamin D screening.Br J Sports Med 52, 522–526.
39.Tajbakhsh, S (2009) Skeletal muscle stem cells in developmental versus regenerative myogenesis. J Intern Med 266, 372–389.
40.Sambasivan, R & Tajbakhsh, S (2007) Skeletal muscle stem cell birth and properties. Semin Cell Dev Biol 18, 870–882.
41.Braun, T & Gautel, M (2011) Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat Rev Mol Cell Biol 12, 349–361.
42.Bentzinger, CF, Wang, YX & Rudnicki, MA (2012) Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol 4, a008342.
43.Pownall, ME, Gustafsson, MK & Emerson, CP Jr (2002) Myogenic regulatory factors and the specification of muscle progenitors in vertebrate embryos. Annu Rev Cell Dev Biol 18, 747–783.
44.Berkes, CA & Tapscott, SJ (2005) MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol 16, 585–595.
45.Valdez, MR, Richardson, JA, Klein, WH, et al. (2000) Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4. Dev Biol 219, 287–298.
46.Domingues-Faria, C, Chanet, A, Salles, J, et al. (2014) Vitamin D deficiency down-regulates Notch pathway contributing to skeletal muscle atrophy in old Wistar rats. Nutr Metab (Lond) 11, 47.
47.Hutton, KC, Vaughn, MA, Litta, G, et al. (2014) Effect of vitamin D status improvement with 25-hydroxycholecalciferol on skeletal muscle growth characteristics and satellite cell activity in broiler chickens. J Anim Sci 92, 3291–3299.
48.Girgis, CM, Clifton-Bligh, RJ, Mokbel, N, et al. (2014) Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 155, 347–357.
49.Bischoff, HA, Borchers, M, Gudat, F, et al. (2001) In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. In situ 33, 19–24.
50.Bischoff-Ferrari, HA, Borchers, M, Gudat, F, et al. (2004) Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 19, 265–269.
51.Ceglia, L, da Silva Morais, M, Park, LK, et al. (2010) Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol 41, 137–142.
52.Girgis, CM, Mokbel, N, Cha, KM, et al. (2014) The vitamin D receptor (VDR) is expressed in skeletal muscle of male mice and modulates 25-hydroxyvitamin D (25OHD) uptake in myofibers. Endocrinology 155, 3227–3237.
53.Oku, Y, Tanabe, R, Nakaoka, K, et al. (2016) Influences of dietary vitamin D restriction on bone strength, body composition and muscle in rats fed a high-fat diet: involvement of mRNA expression of MyoD in skeletal muscle. J Nutr Biochem 32, 85–90.
54.Ray, AD, Personius, KE, Williamson, DL, et al. (2016) Vitamin D3 intake modulates diaphragm but not peripheral muscle force in young mice. J Appl Physiol (1985) 120, 1124–1131.
55.Girgis, CM, Cha, KM, Houweling, PJ, et al. (2015) Vitamin D receptor ablation and vitamin D deficiency result in reduced grip strength, altered muscle fibers, and increased myostatin in mice. Calcif Tissue Int 97, 602–610.
56.Garcia, LA, King, KK, Ferrini, MG, et al. (2011) 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells. Endocrinology 152, 2976–2986.
57.Srikuea, R, Zhang, X, Park-Sarge, OK, et al. (2012) VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation. Am J Physiol Cell Physiol 303, C396–C405.
58.Garcia, LA, Ferrini, MG, Norris, KC, et al. (2013) 1,25(OH)2vitamin D3 enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C2C12 skeletal muscle cells. J Steroid Biochem Mol Biol 133, 1–11.
59.Van der Meijden, K, Bravenboer, N, Dirks, NF, et al. (2016) Effects of 1,25(OH)2D3 and 25(OH)D3 on C2C12 myoblast proliferation, differentiation, and myotube hypertrophy. J Cell Physiol 231, 2517–2528.
60.Irazoqui, AP, Boland, RL & Buitrago, CG (2014) Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells. J Mol Endocrinol 53, 331–343.
61.Braga, M, Simmons, Z, Norris, KC, et al. (2017) Vitamin D induces myogenic differentiation in skeletal muscle derived stem cells. Endocr Connect 6, 139–150.
62.Ryan, KJ, Daniel, ZC, Craggs, LJ, et al. (2013) Dose-dependent effects of vitamin D on transdifferentiation of skeletal muscle cells to adipose cells. J Endocrinol 217, 45–58.
63.Goodpaster, BH, Krishnaswami, S, Resnick, H, et al. (2003) Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26, 372–379.
64.Hilton, TN, Tuttle, LJ, Bohnert, KL, et al. (2008) Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther 88, 1336–1344.
65.Zoico, E, Rossi, A, Di Francesco, V, et al. (2010) Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. J Gerontol A Biol Sci Med Sci 65, 295–299.
66.Matsakas, A & Patel, K (2009) Intracellular signalling pathways regulating the adaptation of skeletal muscle to exercise and nutritional changes. Histol Histopathol 24, 209–222.
67.Trendelenburg, AU, Meyer, A, Rohner, D, et al. (2009) Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296, C1258–C1270.
68.Hay, N & Sonenberg, N (2004) Upstream and downstream of mTOR. Genes Dev 18, 1926–1945.
69.Winbanks, CE, Weeks, KL, Thomson, RE, et al. (2012) Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J Cell Biol 197, 997–1008.
70.Artaza, JN & Norris, KC (2009) Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200, 207–221.
71.Birge, SJ & Haddad, JG (1975) 25-Hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest 56, 1100–1107.
72.Salles, J, Chanet, A, Giraudet, C, et al. (2013) 1,25(OH)2-vitamin D3 enhances the stimulating effect of leucine and insulin on protein synthesis rate through Akt/PKB and mTOR mediated pathways in murine C2C12 skeletal myotubes. Mol Nutr Food Res 57, 2137–2146.
73.Bolster, DR, Jefferson, LS & Kimball, SR (2004) Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling. Proc Nutr Soc 63, 351–356.
74.Proud, CG & Denton, RM (1997) Molecular mechanisms for the control of translation by insulin. Biochem J 328, 329–341.
75.Bhat, M, Kalam, R, Qadri, SS, et al. (2013) Vitamin D deficiency-induced muscle wasting occurs through the ubiquitin proteasome pathway and is partially corrected by calcium in male rats. Endocrinology 154, 4018–4029.
76.Mitch, WE & Goldberg, AL (1996) Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med 335, 1897–1905.
77.Bhat, M & Ismail, A (2015) Vitamin D treatment protects against and reverses oxidative stress induced muscle proteolysis. J Steroid Biochem Mol Biol 152, 171–179.
78.Bruyere, O, Cavalier, E, Souberbielle, JC, et al. (2014) Effects of vitamin D in the elderly population: current status and perspectives. Arch Public Health 72, 32.
79.Deepa, SS, Bhaskaran, S, Ranjit, R, et al. (2016) Down-regulation of the mitochondrial matrix peptidase ClpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation. Free Radic Biol Med 91, 281–292.
80.Sinha, A, Hollingsworth, KG, Ball, S, et al. (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98, E509–E513.
81.Rana, P, Marwaha, RK, Kumar, P, et al. (2014) Effect of vitamin D supplementation on muscle energy phospho-metabolites: a 31P magnetic resonance spectroscopy-based pilot study. Endocr Res 39, 152–156.
82.Boon, N, Hul, GB, Sicard, A, et al. (2006) The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity (Silver Spring) 14, 1739–1746.
83.Silvagno, F & Pescarmona, G (2017) Spotlight on vitamin D receptor, lipid metabolism and mitochondria: some preliminary emerging issues. Mol Cell Endocrinol 450, 24–31.
84.Muñoz Garcia, A, Kutmon, M, Eijssen, L, et al. (2018) Pathway analysis of transcriptomic data shows immunometabolic effects of vitamin D. J Mol Endocrinol 60, 95–108.
85.Calton, EK, Keane, KN, Soares, MJ, et al. (2016) Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults. Redox Biol 10, 243–250.
86.Pramono, A, Jocken, JWE & Blaak, EE (2019) Vitamin D deficiency in the etiology of obesity related insulin resistance. Diabetes Metab Res Rev 2019, e3146.
87.Rudolf, R, Mongillo, M, Magalhaes, PJ, et al. (2004) In vivo monitoring of Ca2+ uptake into mitochondria of mouse skeletal muscle during contraction. J Cell Biol 166, 527–536.
88.Mukherjee, A, Zerwekh, JE, Nicar, MJ, et al. (1981) Effect of chronic vitamin D deficiency on chick heart mitochondrial oxidative phosphorylation.J Mol Cell Cardiol 13, 171–183.
89.Hii, CS & Ferrante, A (2016) The non-genomic actions of vitamin D. Nutrients 8, 135.
90.Bouillon, R, Gielen, E & Vanderschueren, D (2014) Vitamin D receptor and vitamin D action in muscle. Endocrinology 155, 3210–3213.
91.Stratos, I, Li, Z, Herlyn, P, et al. (2013) Vitamin D increases cellular turnover and functionally restores the skeletal muscle after crush injury in rats. Am J Pathol 182, 895–904.
92.Matar, M, Al-Shaar, L, Maalouf, J, et al. (2016) The relationship between calciotropic hormones, IGF-1, and bone mass across pubertal stages. J Clin Endocr Metab 101, 4860–4870.
93.Sollman, AT, Al Khalaf, F, AlHemaidi, N, et al. (2008) Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency. Metabolism 57, 95–102.
94.Trummer, C, Schwetz, V, Pandis, M, et al. (2017) Effects of vitamin D supplementation on IGF-1 and calcitriol: a randomized-controlled trial. Nutrients 9, E623.
95.Huhtakangas, JA, Olivera, CJ, Bishop, JE, et al. (2004) The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18, 2660–2671.
96.Buitrago, CG, Arango, NS & Boland, RL (2012) 1α,25(OH)2D3-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells. J Cell Biochem 113, 1170–1181.
97.Morelli, S, de Boland, AR & Boland, RL (1993) Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblasts treated with 1,25-dihydroxyvitamin D3. Biochem J 289, 675–679.
98.Capiati, DA, Vazquez, G, Tellez Inon, MT, et al. (2000) Role of protein kinase C in 1,25(OH)2-vitamin D3 modulation of intracellular calcium during development of skeletal muscle cells in culture. J Cell Biochem 77, 200–212.
99.Vazquez, G & de Boland, AR (1996) Involvement of protein kinase C in the modulation of 1α,25-dihydroxy-vitamin D3-induced 45Ca2+ uptake in rat and chick cultured myoblasts. Biochim Biophys Acta 1310, 157–162.
100.Vazquez, G, Boland, R & de Boland, AR (1995) Modulation by 1,25(OH)2-vitamin D3 of the adenylyl cyclase/cyclic AMP pathway in rat and chick myoblasts. Biochim Biophys Acta 1269, 91–97.
101.Boland, RL (2011) VDR activation of intracellular signaling pathways in skeletal muscle. Mol Cell Endocrinol 347, 11–16.
102.Morelli, S, Buitrago, C, Boland, R, et al. (2001) The stimulation of MAP kinase by 1,25(OH)2-vitamin D3 in skeletal muscle cells is mediated by protein kinase C and calcium. Mol Cell Endocrinol 173, 41–52.
103.Buitrago, CG, Pardo, VG, de Boland, AR, et al. (2003) Activation of RAF-1 through Ras and protein kinase Cα mediates 1α,25(OH)2-vitamin D3 regulation of the mitogen-activated protein kinase pathway in muscle cells. J Biol Chem 278, 2199–2205.
104.Ronda, AC, Buitrago, C, Colicheo, A, et al. (2007) Activation of MAPKs by 1α,25(OH)2-vitamin D3 and 17β-estradiol in skeletal muscle cells leads to phosphorylation of Elk-1 and CREB transcription factors. J Steroid Biochem Mol Biol 103, 462–466.
105.Buitrago, CG, Ronda, AC, de Boland, AR, et al. (2006) MAP kinases p38 and JNK are activated by the steroid hormone 1α,25(OH)2-vitamin D3 in the C2C12 muscle cell line. J Cell Biochem 97, 698–708.
106.An, SS, Fabry, B, Mellema, M, et al. (2004) Role of heat shock protein 27 in cytoskeletal remodeling of the airway smooth muscle cell. J Appl Physiol (1985) 96, 1701–1713.
107.Ordonez-Moran, P & Munoz, A (2009) Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 8, 1675–1680.
108.Yoshikawa, S, Nakamura, T, Tanabe, H, et al. (1979) Osteomalacic myopathy. Endocrinol Jpn 26, 65–72.
109.Ceglia, L, Niramitmahapanya, S, da Silva Morais, M, et al. (2013) A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. J Clin Endocrinol Metab 98, E1927–E1935.
110.Sorensen, OH, Lund, B, Saltin, B, et al. (1979) Myopathy in bone loss of ageing: improvement by treatment with 1 α-hydroxycholecalciferol and calcium. Clin Sci (Lond) 56, 157–161.
111.Freedman, LP (1999) Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation. J Nutr 129, 581S–586S.
112.Sato, Y, Iwamoto, J, Kanoko, T, et al. (2005) Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 20, 187–192.
113.Wyon, MA, Koutedakis, Y, Wolman, R, et al. (2014) The influence of winter vitamin D supplementation on muscle function and injury occurrence in elite ballet dancers: a controlled study.J Sci Med Sport 17, 8–12.
114.Muir, SW & Montero-Odasso, M (2011) Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 59, 2291–2300.
115.Stockton, KA, Mengersen, K, Paratz, JD, et al. (2011) Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 22, 859–871.
116.Beaudart, C, Buckinx, F, Rabenda, V, et al. (2014) The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 99, 4336–4345.
117.Houston, DK, Tooze, JA, Davis, CC, et al. (2011) Serum 25-hydroxyvitamin D and physical function in older adults: the Cardiovascular Health Study All Stars. J Am Geriatr Soc 59, 1793–1801.
118.Menant, JC, Close, JCT, Delbaere, K, et al. (2012) Relationships between serum vitamin D levels, neuromuscular and neuropsychological function and falls in older men and women. Osteoporosis Int 23, 981–989.
119.Scott, D, Blizzard, L, Fell, J, et al. (2010) A prospective study of the associations between 25-hydroxyvitamin D, sarcopenia progression and physical activity in older adults. Clin Endocrinol 73, 581–587.
120.Michael, YL, Smit, E, Seguin, R, et al. (2011) Serum 25-hydroxyvitamin D and physical performance in postmenopausal women. J Womens Health (Larchmt) 20, 1603–1608.
121.Houston, DK, Tooze, JA, Neiberg, RH, et al. (2012) 25-Hydroxyvitamin D status and change in physical performance and strength in older adults: the Health, Aging, and Body Composition Study. Am J Epidemiol 176, 1025–1034.
122.Antoniak, AE & Greig, CA (2017) The effect of combined resistance exercise training and vitamin D3 supplementation on musculoskeletal health and function in older adults: a systematic review and meta-analysis. BMJ Open 7, e014619.
123.Chanet, A, Verlaan, S, Salles, J, et al. (2017) Supplementing breakfast with a vitamin D and leucine-enriched whey protein medical nutrition drink enhances postprandial muscle protein synthesis and muscle mass in healthy older men. J Nutr 147, 2262–2271.
124.Wagatsuma, A & Sakuma, K (2014) Vitamin D signaling in myogenesis: potential for treatment of sarcopenia. Biomed Res Int 2014, 121254.
125.Sadat-Ali, M, Al Elq, AH, Al-Turki, HA, et al. (2011) Influence of vitamin D levels on bone mineral density and osteoporosis. Ann Saudi Med 31, 602–608.
126.Neal, S, Sykes, J, Rigby, M, et al. (2015) A review and clinical summary of vitamin D in regard to bone health and athletic performance. Phys Sportsmed 43, 161–168.
127.Lips, P, Gielen, E & van Schoor, NM (2014) Vitamin D supplements with or without calcium to prevent fractures. Bonekey Rep 3, 512.
128.Ross, AC, Manson, JE, Abrams, SA, et al. (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96, 53–58.
129.Zhao, JG, Zeng, XT, Wang, J, et al. (2017) Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis. JAMA 318, 2466–2482.
130.Barker, T, Schneider, ED, Dixon, BM, et al. (2013) Supplemental vitamin D enhances the recovery in peak isometric force shortly after intense exercise. Nutr Metab (Lond) 10, 69.
131.Close, GL, Leckey, J, Patterson, M, et al. (2013) The effects of vitamin D3 supplementation on serum total 25[OH]D concentration and physical performance: a randomised dose–response study. Br J Sports Med 47, 692–696.
132.Close, GL, Russell, J, Cobley, JN, et al. (2013) Assessment of vitamin D concentration in non-supplemented professional athletes and healthy adults during the winter months in the UK: implications for skeletal muscle function. J Sports Sci 31, 344–353.
133.Dubnov-Raz, G, Livne, N, Raz, R, et al. (2015) Vitamin D supplementation and physical performance in adolescent swimmers. Int J Sport Nutr Exerc Metab 25, 317–325.
134.Todd, JJ, McSorley, EM, Pourshahidi, LK, et al. (2017) Vitamin D3 supplementation using an oral spray solution resolves deficiency but has no effect on VO2 max in Gaelic footballers: results from a randomised, double-blind, placebo-controlled trial. Eur J Nutr 56, 1577–1587.
135.Fairbairn, KA, Ceelen, IJM, Skeaff, CM, et al. (2018) Vitamin D3 supplementation does not improve sprint performance in professional rugby players: a randomized, placebo-controlled, double-blind intervention study. Int J Sport Nutr Exerc Metab 28, 1–9.
136.Jastrzebska, M, Kaczmarczyk, M & Jastrzebski, Z (2016) Effect of vitamin D supplementation on training adaptation in well-trained soccer players. J Strength Cond Res 30, 2648–2655.
137.Farrokhyar, F, Sivakumar, G, Savage, K, et al. (2017) Effects of vitamin D supplementation on serum 25-hydroxyvitamin D concentrations and physical performance in athletes: a systematic review and meta-analysis of randomized controlled trials. Sports Medicine 47, 2323–2339.
138.Aloia, JF & Li-Ng, M (2007) Re: epidemic influenza and vitamin D. Epidemiol Infect 135, 1095–1096; author reply 1097–1098.
139.Giovannucci, E (2009) Vitamin D and cardiovascular disease. Curr Atheroscler Rep 11, 456–461.
140.Lappe, JM, Travers-Gustafson, D, Davies, KM, et al. (2007) Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586–1591.
141.Heaney, RP, Dowell, MS, Hale, CA, et al. (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22, 142–146.
142.Trivedi, DP, Doll, R & Khaw, KT (2003) Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326, 469.
143.Bischoff-Ferrari, HA, Willett, WC, Wong, JB, et al. (2005) Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 293, 2257–2264.
144.Bischoff-Ferrari, HA, Willett, WC, Wong, JB, et al. (2009) Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 169, 551–561.
145.Biesalski, HK, Aggett, PJ, Anton, R, et al. (2011) 26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: evidence-based nutrition. Nutrition 27, S1–S20.
146.Heaney, RP & Holick, MF (2011) Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 26, 455–457.
147.Bischoff-Ferrari, HA, Giovannucci, E, Willett, WC, et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84, 18–28.